ABBV-744
Iinkcukacha zeMveliso
Iithegi zeMveliso
| Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
| 100mg | KwiZitokhwe | 300 |
| 500mg | KwiZitokhwe | 850 |
| 1g | KwiZitokhwe | 1250 |
| Ubungakanani obungakumbi | Fumana iiQuotes | fumana iiQuotes |
Igama leMchiza:
N-ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-6,7-dihydro-1H -pyrrolo[2,3-c]pyridine-2-carboxamide
Ikhowudi yoncumo:
O=C(C(N1)=CC(C(C2=CC(C)(O)C)=CC=C2OC3=C(C)C=C(F)C=C3C)=CN4C)=C1C4 =O)NCC
Ikhowudi ye-InChi:
InChI=1S/C28H30FN3O4/c1-7-30-26(33)22-13-20-21(14-32(6)27(34)24(20)31-22)19-12-17(28( 4,5)35)8-9-23(19)36-25-15(2)10-18(29)11-16(25)3/h8-14,31,35H,7H2,1-6H3, (H,30,33)
Isitshixo se-InChi:
OEDSFMUSNZDJFD-UHFFFAOYSA-N
Igama elingundoqo:
ABBV-744, ABBV 744, ABBV744, 2138861-99-9
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga).
Inkcazo:
I-ABBV-744 yi-BDII-ekhethiweyo ye-BET bromodomain inhibitor ephandwayo ukunyanga i-AML kunye ne-metastic castration-resistant cancer prostate.
Ithagethi: BET bromodomain